Sfoglia per RIVISTA
HEMATOLOGICAL ONCOLOGY
Collezione AO Cuneo

  

Items : 6

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Visco C; Corradini P; Passamonti F; Bertù L; Guidetti A; Gherlinzoni F; Pagano L; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Cilloni D; Della Porta MG; Coviello E; Mohamed S; Mauro FR; Gentile M; Gambacorti-Passerini C; Bocchia M; Massaia M; Billio A; Fracchiolla NS; Marchesi F; Scattolin A; Trentin L; Cattaneo C; Derenzini E; Cavo M; et alii...

Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):415-423. doi: 10.1002/hon.3117. Epub 2023 Jan 4.

2023
AO Cuneo

Biggi A; Chauvie S; Fallanca F; Guerra L; Bergesio F; Menga M; Bianchi A; Gregianin M; Chiaravalloti A; Schillaci O; Pavoni C; Patti C; Picardi M; Romano A; Schiavotto C; Sorasio R; Viviani S; La Nasa G; Trentin L; Rambaldi A; Gallamini A;

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):846-856. doi: 10.1002/hon.3048. Epub 2022 Aug 12.

2022
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Passamonti F; Antonio Grossi P; Bruno R; Pagano L; Luppi M; Busca A; Giuliani N; Corso A; Mohamed S; Tosi P; Giovanni Della Porta M; Lanza F; Rigacci L; Massimo Lemoli R; Venditti A; Tafuri A; Billio A; Gentile M; Falini B; Turrini M; Chiara Tisi M; Morotti A; Coviello E; Trentin L; Bocchia M; Galimberti S; Cuneo A; Musto P; et alii...

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.

2021
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pietrasanta D; Foà R; Chiarenza A; Penna G; Orsucci L; Levato L; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Murru R; Leone M; Baratè C; Olivieri J; Tisi MC; Stefoni V; Malerba L; Ibatici A; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Farina L; Re F; De Paoli L; Foglietta M; Giordano A; et alii...

Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):501-508. doi: 10.1002/hon.2775. Epub 2020 Jul 30.

2020
AO Cuneo
AO Ordine Mauriziano

Gianni AM; Gallamini A; Corradini P; Galbiati M; Ferreri AJM; Farina L; Zanotti R; Cimminiello M; Tarella C; Gottardi D; Guidetti A; Trentin L; Sorasio R; Romano A; Patti C; Rossi A; Taverna F; Rambaldi A; Pavoni C; Mazzocchi A; Viviani S;

2017
AO Cuneo

Ceriani L; Barrington S; Biggi A; Malkowski B; Metser U; Versari A; Martelli M; Davies A; Johnson PW; Zucca E; Chauvie S;